- Home
- CERS vs GAU Comparison
CERS vs GAU Comparison
Compare CERS & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- GAU
- Stock Information
- Founded
- CERS 1991
- GAU 1999
- Country
- CERS United States
- GAU Canada
- Employees
- CERS N/A
- GAU N/A
- Industry
- CERS EDP Services
- GAU
- Sector
- CERS Technology
- GAU
- Exchange
- CERS Nasdaq
- GAU Nasdaq
- Market Cap
- CERS 347.3M
- GAU 323.9M
- IPO Year
- CERS 1997
- GAU N/A
- Fundamental
- Price
- CERS $1.65
- GAU $1.31
- Analyst Decision
- CERS Buy
- GAU Strong Buy
- Analyst Count
- CERS 3
- GAU 2
- Target Price
- CERS $3.17
- GAU $2.53
- AVG Volume (30 Days)
- CERS 1.6M
- GAU 829.0K
- Earning Date
- CERS 02-20-2025
- GAU 03-04-2025
- Dividend Yield
- CERS N/A
- GAU N/A
- EPS Growth
- CERS N/A
- GAU N/A
- EPS
- CERS N/A
- GAU N/A
- Revenue
- CERS $180,270,000.00
- GAU $166,788,000.00
- Revenue This Year
- CERS $15.95
- GAU N/A
- Revenue Next Year
- CERS $10.50
- GAU $44.80
- P/E Ratio
- CERS N/A
- GAU N/A
- Revenue Growth
- CERS 15.29
- GAU N/A
- 52 Week Low
- CERS $1.38
- GAU $0.89
- 52 Week High
- CERS $2.59
- GAU $2.00
- Technical
- Relative Strength Index (RSI)
- CERS 41.40
- GAU 59.31
- Support Level
- CERS $1.64
- GAU $1.17
- Resistance Level
- CERS $1.96
- GAU $1.35
- Average True Range (ATR)
- CERS 0.11
- GAU 0.06
- MACD
- CERS -0.02
- GAU 0.02
- Stochastic Oscillator
- CERS 3.12
- GAU 78.57
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages the Asanko Gold Mine, located in Ghana, West Africa. Its Asanko Gold Mine is a multi-deposit complex, with two main deposits, the Obotan Project and the Esaase Project, both located in the Amansie West District of the Republic of Ghana, West Africa.